A national survey shows how drug shortages led to treatment changes and delays.
Certain cancer drugs were in such short supply in 2011 that patients were going without, taking untested medications and were subjected to prescription errors because of changes in routine, finds a survey of health professionals published today.
Almost all of the 240 hospital and clinic pharmacists polled said they had to change or delay treatments because of the shortages, said the study, by researchers at St. Jude Children’s Research Hospital in Memphis. It was published in the American Journal of Health-System Pharmacy.
